QA7.F - Qubicgames SA

Frankfurt - Frankfurt Delayed Price. Currency in EUR
+0.0010 (+0.36%)
At close: 08:01AM CEST
Stock chart is not supported by your current browser
Previous Close0.2780
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range0.2790 - 0.2790
52 Week Range0.1885 - 0.3960
Avg. Volume16
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights

    --Cash runway extended late into calendar Q2 2023 --Tumor control achieved following MDNA11 treatment in 3 out of 8 patients enrolled in first 3 dose escalation cohorts of the ABILITY Phase 1/2 Study. -- Pharmacodynamic data show superior dose-dependent increase in stimulation of anti-cancer immune cells when compared to competing IL-2 programs in the clinic -- Management hosting conference call and webcast today at 8:30 AM ET TORONTO and HOUSTON, June 22, 2022 (GLOBE NEWSWIRE) -- Medicenna Ther